Evidence map›Paper›PMID 27696232›Full record

ArticleEndocrine2017

Correlation of BRAF mutation and SUV

Aysenur Ozderya, Sule Temizkan, Aylin Ege Gul, Sule Ozugur, Mehmet Sargin, Kadriye Aydin

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Focal Thyroid Incidentalomas onFrontiers in endocrinology · 2021
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aysenur OzderyaDepartment of Endocrinology and Metabolism, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey.
Sule TemizkanDepartment of Endocrinology and Metabolism, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey. suletemizkan@yahoo.com.
Aylin Ege GulDepartment of Pathology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey.
Sule OzugurDepartment of Nuclear Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey.
Mehmet SarginDepartment of Family Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey.
Kadriye AydinDepartment of Endocrinology and Metabolism, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, 34890, Turkey.
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic importance of

Indexed as

AdultCarcinoma, PapillaryFemaleFluorodeoxyglucose F18HumansIncidental FindingsMaleMiddle AgedMutationPositron-Emission TomographyProto-Oncogene Proteins B-rafRadiopharmaceuticalsRetrospective StudiesThyroid GlandThyroid NeoplasmsBRAF protein, humanFluorodeoxyglucose F18Proto-Oncogene Proteins B-rafRadiopharmaceuticals18FDG-PETBRAFDifferantiated thyroid cancerP53 protein expression

Identifiers

PMID27696232
OpenAlexW2526338100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.